Decabromodiphenyl ether exposure reduces dabrafenib sensitivity of papillary thyroid carcinoma harboring BRAFV600E mutation through the EGFR-CRAF-MAPK pathway: An in vitro study
- Resource Type
- Article
- Source
- In
Toxicology May 2024 504 - Subject
- Language
- ISSN
- 0300-483X